AHF Sounds Alarm Over Latest UNAIDS Data

WASHINGTON–(BUSINESS WIRE)–In light of a worrisome funding update and the recent release of the 2018 global HIV/AIDS statistics by the Joint United Nations Programme on HIV/AIDS (UNAIDS), AIDS Healthcare Foundation (AHF) is sounding the alarm on the crisis by calling for increased data accuracy measures and an urgent recommitment to fully funding the Global Fund … [Read more…]

Dr. Reddy’s Laboratories announces closure of the transaction to divest ZEMBRACE® SYMTOUCH® and TOSYMRA™ to Upsher-Smith Laboratories, LLC

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY), announces the closure of the transaction with Upsher-Smith Laboratories, LLC (Upsher-Smith), pursuant to the satisfactory completion of all customary closing conditions including the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act), as amended. Under the … [Read more…]

Elevation Foods Recalls Packaged Egg Salad, Tuna Salad, Thai Lobster Salad, and Archer Farms Deviled Egg Sandwiches Because of Possible Health Risk

KNOXVILLE, Tenn.–(BUSINESS WIRE)–Elevation Foods is voluntarily recalling containers of Archer Farms-brand egg salad; Freskët-brand egg salad, tuna salad, and Thai lobster salad; and Archer Farms-brand deviled egg sandwiches produced on June 18, 2019 due to possible contamination with Listeria monocytogenes. Listeria monocytogenes is an organism which can cause serious and sometimes fatal infections in young … [Read more…]

FDA Accepts and Files 22nd Century Group’s Modified Risk Tobacco Product Application for VLN™ Cigarettes

WILLIAMSVILLE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a world leader in tobacco harm reduction, announced today that the U.S. Food and Drug Administration (FDA) accepted and filed for substantive scientific review the Company’s Modified Risk Tobacco Product (MRTP) application for its exclusive Very Low Nicotine Content (VLNC) … [Read more…]

AVROBIO Announces Closing of Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

CAMBRIDGE, Mass.–(BUSINESS WIRE)–AVROBIO, Inc. (NASDAQ: AVRO) (the “Company”), a Phase 2 clinical-stage gene therapy company, today announced the closing of its previously announced underwritten public offering of 7,475,000 shares of its common stock, including 975,000 shares of its common stock pursuant to the underwriters’ exercise in full of their option to purchase additional shares at … [Read more…]

Apollo Endosurgery, Inc. to Report Second Quarter Results on July 23, 2019

AUSTIN, Texas–(BUSINESS WIRE)–Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the first quarter ended June 30, 2019 on Tuesday, July 23, 2019, after the U.S. stock markets close. Apollo will hold a … [Read more…]

Global Healthy Living Foundation Urges Presidential Candidates to Support the Rescheduling of Marijuana to Improve Access by Chronic Disease Patients

Organization Supports Regulated, Robust Clinical Trials to Understand the Potential Efficacy and Safety of Medical Marijuana Across Disease Conditions UPPER NYACK, N.Y.–(BUSINESS WIRE)–#arthritis–The Global Healthy Living Foundation urges 2020 Presidential candidates to support the rescheduling of marijuana so that it, along with CBD products, can be tested under controlled parameters and with peer review to … [Read more…]

Afya Educacional (NASDAQ:AFYA) Lists on NASDAQ

Brazil’s largest medical education group seeks to transform medical education NEW YORK–(BUSINESS WIRE)–Today, Afya Educacional (“Afya” or “the Company”), Brazil’s largest medical education group,1 lists on the Nasdaq under the ticker symbol NASDAQ:AFYA. The initial public offering of 13,744,210 Class A common shares is priced at $19.00 per share. Afya is the first company in … [Read more…]

Rising Pharmaceuticals Announces the U.S. Launch of a Generic Version of Pregabalin Capsules

SADDLEBROOK, N.J.–(BUSINESS WIRE)–Rising Pharmaceuticals, a Rising Pharma Holdings Inc. company, today announced the U.S. launch & commercial shipment of a generic version of Lyrica®, (pregabalin) Capsules, in all eight commercially available strengths (25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, & 300 mg. Pregabalin Capsules had U.S. sales of … [Read more…]